New Coverage
Provided by:
Set Up E-mail Alerts For New Coverage »
A complete list of daily analyst stock rating initiations from across Wall Street including the reasoning behind the change. Upgrade to StreetInsider.com Premium for a comprehensive listing of all today's new coverage and historical new coverage. For a summary of today's upgrade/downgrade activity please visit Ratings Insider.
-
-
-
-
-
-
-
H.C. Wainwright Starts Jasper Therapeutics (JSPR) at Buy, "an underappreciated gem in the autoimmune and inflammatory disease space"
-
-
-
-
-
-
-
JPMorgan Starts PACS Group (PACS) at Overweight
-
-
-
-
-
-
-
Wells Fargo Starts Kiniksa (KNSA) at Overweight, 'we see +15-25% upside potential'
-
-
-
-
-
-
-
Piper Sandler Starts Zura Bio Ltd. (ZURA) at Overweight
-
-
-
-
-
-
-
Stifel Starts Phathom Pharmaceuticals (PHAT) at Buy
-
-
-
-
-
-
-
Cantor Fitzgerald Starts Tesla (TSLA) at Overweight, 'good entry-point for investors'
-
-
-
-
-
-
-
Exane BNP Paribas Starts Galderma Group AG (GALD:SW) at Outperform
-
128,115 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving New Coverage reports.